About Vaccines 2026 | Hybrid Event
We are delighted to announce the 3rd Edition of the International Vaccine Congress
(Vaccines 2026), scheduled to take place from September 14–16, 2026, in Rome, Italy, and virtually.
This prestigious hybrid event brings together global leaders in vaccine
research, development, and policy to explore the latest scientific advances and
collaborative strategies in the field of immunization.
Under the theme “Innovating for Immunity: Vaccines in the
Era of Global Challenges” the congress aims to highlight
groundbreaking discoveries, emerging technologies, and forward-thinking
approaches that are transforming the landscape of vaccine research and public
health worldwide.
Vaccines 2026 invites scientists,
immunologists, microbiologists, epidemiologists, clinical researchers, public
health officials, pharmaceutical experts, and policymakers to join an
interactive platform designed to foster meaningful dialogue, collaboration, and
innovation.
The scientific
sessions will span a wide spectrum of topics — from vaccine discovery, delivery systems, and clinical trials
to pandemic preparedness, global
immunization policies, and the integration of digital health tools.
Attendees can expect high-level presentations, keynote addresses, panel
discussions, and networking opportunities that connect academia, industry, and
government stakeholders.
Set against the
inspiring backdrop of Rome, Italy — the
Eternal City, Vaccines 2026 offers a unique opportunity to engage with
global experts while experiencing one of the world’s most historic and
beautiful destinations. Participants may also join virtually, ensuring access
and inclusivity for attendees across all regions.
Join us in advancing the science of immunization and shaping the future of global health at the 3rd International Vaccine Congress – Vaccines 2026, in Rome, Italy, and Online.